{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T07:29:56Z","timestamp":1773818996978,"version":"3.50.1"},"reference-count":102,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2006,8,1]],"date-time":"2006-08-01T00:00:00Z","timestamp":1154390400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Best Practice &amp; Research Clinical Rheumatology"],"published-print":{"date-parts":[[2006,8]]},"DOI":"10.1016\/j.berh.2006.05.006","type":"journal-article","created":{"date-parts":[[2006,9,20]],"date-time":"2006-09-20T07:42:25Z","timestamp":1158738145000},"page":"673-684","source":"Crossref","is-referenced-by-count":19,"title":["Gout: can we create an evidence-based systematic approach to diagnosis and management?"],"prefix":"10.1016","volume":"20","author":[{"given":"Lan X.","family":"Chen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H. Ralph","family":"Schumacher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.berh.2006.05.006_bib1","doi-asserted-by":"crossref","first-page":"499","DOI":"10.7326\/0003-4819-143-7-200510040-00009","article-title":"Pathogenesis of gout","volume":"143","author":"Choi","year":"2005","journal-title":"Annals of Internal Medicine"},{"key":"10.1016\/j.berh.2006.05.006_bib2","first-page":"133","article-title":"Monosodium urate crystal deposition arthropathy. Part I: Review of the stages and diagnosis of gout","volume":"5","author":"Schumacher","year":"2005","journal-title":"Advanced Studies in Medicine"},{"key":"10.1016\/j.berh.2006.05.006_bib3","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1002\/art.1780290610","article-title":"Reproducibility of synovial fluid analyses: a study among 4 laboratories","volume":"29","author":"Schumacher","year":"1986","journal-title":"Arthritis and Rheumatism"},{"key":"10.1016\/j.berh.2006.05.006_bib4","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1136\/ard.2004.027268","article-title":"Analysis for crystals in synovial fluid: training of the analysis results in high consistency","volume":"64","author":"Lumbreras","year":"2005","journal-title":"Annals of the Rheumatic Diseases"},{"key":"10.1016\/j.berh.2006.05.006_bib5","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1097\/00124743-199804000-00015","article-title":"Identification of pathologic synovial fluid crystals on Gram stains","volume":"4","author":"Petrocelli","year":"1998","journal-title":"Journal of Clinical Rheumatology"},{"key":"10.1016\/j.berh.2006.05.006_bib6","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1097\/01.bor.0000209430.59226.0f","article-title":"Current trends in crystal identification","volume":"18","author":"Chen","year":"2006","journal-title":"Current Opinion in Rheumatology"},{"issue":"supplement","key":"10.1016\/j.berh.2006.05.006_bib7","first-page":"S108","article-title":"Reduction in gout flares in subjects with chronic gout treated with febuxostat or allopurinol for 52 weeks. The FACT trial","volume":"52","author":"Becker","year":"2005","journal-title":"Arthritis and Rheumatism"},{"issue":"supplement","key":"10.1016\/j.berh.2006.05.006_bib8","first-page":"S105","article-title":"Preliminary identification of potential items for a definition of a gout flare using Delphi methodology","volume":"52","author":"Grainger","year":"2005","journal-title":"Arthritis and Rheumatism"},{"key":"10.1016\/j.berh.2006.05.006_bib9","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1002\/art.1780200320","article-title":"Preliminary criteria for the classification of the acute arthritis of primary gout","volume":"20","author":"Wallace","year":"1972","journal-title":"Arthritis and Rheumatism"},{"key":"10.1016\/j.berh.2006.05.006_bib10","first-page":"2452","article-title":"OMERACT 7. Special interest group on outcome measures for acute and chronic gout","volume":"32","author":"Schumacher","year":"2005","journal-title":"The Journal of Rheumatology"},{"key":"10.1016\/j.berh.2006.05.006_bib11","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1056\/NEJMp048015","article-title":"Uric acid and diet \u2013 insights into the epidemic of cardiovascular disease","volume":"350","author":"Johnson","year":"2004","journal-title":"The\u00a0New England Journal of Medicine"},{"key":"10.1016\/j.berh.2006.05.006_bib12","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1093\/oxfordjournals.aje.a117479","article-title":"Relation of serum uric acid to mortality and ischemic heart disease: the NHANES I epidemiologic follow up study","volume":"141","author":"Freedman","year":"1995","journal-title":"American Journal of Epidemiology"},{"key":"10.1016\/j.berh.2006.05.006_bib13","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1016\/j.amjmed.2005.03.043","article-title":"Serum uric acid and cardiovascular disease: recent developments, and where do they leave us?","volume":"118","author":"Baker","year":"2005","journal-title":"The American Journal of Medicine"},{"key":"10.1016\/j.berh.2006.05.006_bib14","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1001\/archinte.164.14.1546","article-title":"Uric acid level as a risk factor for cardiovascular and all-cause mortality in middle-aged men","volume":"164","author":"Niskanen","year":"2004","journal-title":"Archives of Internal Medicine"},{"key":"10.1016\/j.berh.2006.05.006_bib15","first-page":"906","article-title":"Serum uric acid concentration as a risk factor for cardiovascular mortality: a longterm cohort study of atomic bomb survivors","volume":"32","author":"Hakoda","year":"2005","journal-title":"The Journal of Rheumatology"},{"key":"10.1016\/j.berh.2006.05.006_bib16","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1056\/NEJM198001313020502","article-title":"Sulfinpyrazone in the prevention of sudden death after myocardial infarction","volume":"302","year":"1980","journal-title":"The New England Journal of Medicine"},{"key":"10.1016\/j.berh.2006.05.006_bib17","first-page":"237","article-title":"Sulfinpyrazone in post-myocardial infarction. Report form the Anturan Reinfarction Italian Study","volume":"1","year":"1982","journal-title":"Lancet"},{"key":"10.1016\/j.berh.2006.05.006_bib18","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1111\/j.1523-1755.2004.00484.x","article-title":"The impact of serum uric acid on cardiovascular outcomes in the LIFE study","volume":"65","author":"Hoieggen A","year":"2004","journal-title":"Kidney International"},{"key":"10.1016\/j.berh.2006.05.006_bib19","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/0002-9343(87)90441-4","article-title":"Asymptomatic hyperuricemia: risks and consequences in the Normative Aging Study","volume":"82","author":"Campion","year":"1987","journal-title":"The American Journal of Medicine"},{"key":"10.1016\/j.berh.2006.05.006_bib20","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/0002-9343(79)90076-7","article-title":"Renal outcomes of gout and hyperuricemia","volume":"67","author":"Fessel","year":"1979","journal-title":"The American Journal of Medicine"},{"key":"10.1016\/j.berh.2006.05.006_bib21","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1097\/01.rhu.0000147049.12220.32","article-title":"Prevalence of comorbid conditions and prescription medication use among patients with gout and hyperuricemia in a managed care setting","volume":"10","author":"Riedel","year":"2004","journal-title":"Journal of Clinical Rheumatology"},{"key":"10.1016\/j.berh.2006.05.006_bib22","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1097\/01.rhu.0000129082.42094.fc","article-title":"Metabolic syndrome and ischemic heart disease in gout","volume":"10","author":"V\u00e1zquez-Mellado","year":"2004","journal-title":"Journal of Clinical Rheumatology"},{"key":"10.1016\/j.berh.2006.05.006_bib23","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1111\/j.1445-5994.1987.tb01232.x","article-title":"Does colchicine work? The results of the first controlled study in acute gout","volume":"17","author":"Ahern","year":"1987","journal-title":"Australian and New Zealand Journal of Medicine"},{"key":"10.1016\/j.berh.2006.05.006_bib24","series-title":"Evidence Based Rheumatology","first-page":"65","article-title":"Gout","author":"Schlesinger","year":"2004"},{"key":"10.1016\/j.berh.2006.05.006_bib25","first-page":"231","article-title":"What is the optimal treatment for acute crystal-induced arthritis?","volume":"63","author":"Pawlotsky","year":"1996","journal-title":"Revue du Rhumatisme English Ed"},{"key":"10.1016\/j.berh.2006.05.006_bib26","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1136\/ard.32.4.351","article-title":"Comparison of indomethacin and phenylbutazone in acute gout","volume":"32","author":"Smyth","year":"1973","journal-title":"Annals of the Rheumatic Diseases"},{"issue":"supplement","key":"10.1016\/j.berh.2006.05.006_bib27","first-page":"15","article-title":"Treatment of acute gouty arthritis with proquazone and indomethacin: a comparative double-blind trial","volume":"21","author":"Ruosti","year":"1978","journal-title":"Scandinavian Journal of Rheumatology"},{"key":"10.1016\/j.berh.2006.05.006_bib28","first-page":"1422","article-title":"Ketoprofen versus indomethacin in patients with acute gouty arthritis: a multicenter, double blind comparative study","volume":"15","author":"Altman","year":"1988","journal-title":"The Journal of Rheumatology"},{"key":"10.1016\/j.berh.2006.05.006_bib29","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1002\/art.1780220420","article-title":"Double blind study of phenoprofen versus phenylbutazone in acute gouty arthritis","volume":"22","author":"Weiner","year":"1979","journal-title":"Arthritis and Rheumatism"},{"key":"10.1016\/j.berh.2006.05.006_bib30","first-page":"344","article-title":"A double-blind comparison of etodolac (Lodine) and high doses of naproxen in the treatment of acute gout","volume":"7","author":"Lederman","year":"1990","journal-title":"Advances in Therapy"},{"key":"10.1016\/j.berh.2006.05.006_bib31","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/S0196-0644(95)70037-4","article-title":"Randomized double-blind comparison of the analgesic efficacy of intramuscular ketorolac and oral indomethacin in the treatment of acute gouty arthritis","volume":"26","author":"Shrestha","year":"1995","journal-title":"Annals of Emergency Medicine"},{"key":"10.1016\/j.berh.2006.05.006_bib32","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1185\/03007999109111513","article-title":"Effectiveness of etodolac (Lodine) compared with naproxen in patients with acute gout","volume":"12","author":"Maccagno","year":"1991","journal-title":"Current Medical Research and Opinion"},{"key":"10.1016\/j.berh.2006.05.006_bib33","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1136\/bmj.324.7352.1488","article-title":"Randomized double-blind trial of etoricoxib and indomethacin in treatment of acute gouty arthritis","volume":"324","author":"Schumacher","year":"2002","journal-title":"BMJ (Clinical Research Ed.)"},{"key":"10.1016\/j.berh.2006.05.006_bib34","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1002\/art.20007","article-title":"Efficacy and safety profile of treatment with etoricoxib 120mg once daily compared with indomethacin 50mg three times daily in acute gout","volume":"50","author":"Rubin","year":"2004","journal-title":"Arthritis and Rheumatism"},{"key":"10.1016\/j.berh.2006.05.006_bib35","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/S0149-2918(04)90035-5","article-title":"A single-blind, randomized, controlled trial to assess the efficacy and tolerability of rofecoxib, diclofenac sodium, and meloxicam in patients with acute gouty arthritis","volume":"26","author":"Cheng","year":"2004","journal-title":"Clinical Therapeutics"},{"key":"10.1016\/j.berh.2006.05.006_bib36","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/0049-0172(90)90070-V","article-title":"Systemic steroid therapy for acute gout: a clinical trial and review of the literature","volume":"19","author":"Groff","year":"1990","journal-title":"Seminars in Arthritis and Rheumatism"},{"key":"10.1016\/j.berh.2006.05.006_bib37","first-page":"2285","article-title":"Treatment of acute attacks of gout with small doses of intraarticular triamcinolone acetonide","volume":"26","author":"Fernandez","year":"1999","journal-title":"The Journal of Rheumatology"},{"key":"10.1016\/j.berh.2006.05.006_bib38","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1097\/00007611-194908000-00019","article-title":"Relief of the symptoms of acute gout and rheumatoid arthritis by means of pituitary adrenocorticotropic hormone (ACTH)","volume":"42","author":"Spies","year":"1949","journal-title":"Southern Medical Journal"},{"key":"10.1016\/j.berh.2006.05.006_bib39","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/0002-9343(50)90004-0","article-title":"Effects of adrenocorticotropic hormone (ACTH) in gout","volume":"9","author":"Gutman","year":"1950","journal-title":"The American Journal of Medicine"},{"key":"10.1016\/j.berh.2006.05.006_bib40","first-page":"696","article-title":"ACTH revisited: effective treatment for acute crystal induced synovitis in patients with multiple medical problems","volume":"21","author":"Ritter","year":"1994","journal-title":"The Journal of Rheumatology"},{"key":"10.1016\/j.berh.2006.05.006_bib41","first-page":"111","article-title":"Comparison of triamcinolone acetonide with indomethacin in the treatment of acute gouty arthritis","volume":"20","author":"Alloway","year":"1993","journal-title":"The Journal of Rheumatology"},{"key":"10.1016\/j.berh.2006.05.006_bib42","first-page":"1325","article-title":"Comparison of adrenocorticotropic hormone and triamcinolone acetonide in the treatment of gouty arthritis","volume":"21","author":"Siegel","year":"1994","journal-title":"The Journal of Rheumatology"},{"key":"10.1016\/j.berh.2006.05.006_bib43","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1002\/art.1780310618","article-title":"Comparison of parenteral adrenocorticotropic hormone with oral indomethacin in the treatment of acute gout","volume":"31","author":"Axelrod","year":"1988","journal-title":"Arthritis and Rheumatism"},{"key":"10.1016\/j.berh.2006.05.006_bib44","doi-asserted-by":"crossref","first-page":"2765","DOI":"10.1002\/art.10526","article-title":"Activation of melanocortin type 3 receptor as a molecular mechanism for adreno-corticotropic hormone efficacy in gouty arthritis","volume":"46","author":"Getting","year":"2002","journal-title":"Arthritis and Rheumatism"},{"key":"10.1016\/j.berh.2006.05.006_bib45","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1002\/art.1780170510","article-title":"Effects of cold and heat on urate crystal-induced synovitis in the dog","volume":"17","author":"Dorwart","year":"1974","journal-title":"Arthritis and Rheumatism"},{"key":"10.1016\/j.berh.2006.05.006_bib46","first-page":"331","article-title":"Local ice therapy during bouts of acute gouty arthritis","volume":"29","author":"Schlesinger","year":"2002","journal-title":"The\u00a0Journal of Rheumatology"},{"key":"10.1016\/j.berh.2006.05.006_bib47","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1002\/art.1780150607","article-title":"Effect of exercise on urate crystal-induced inflammation in canine joints","volume":"15","author":"Agudelo","year":"1972","journal-title":"Arthritis and Rheumatism"},{"key":"10.1016\/j.berh.2006.05.006_bib48","first-page":"409","article-title":"Comparative trial of azapropazone and indomethacin plus allopurinol in acute gout and hyperuricaemia","volume":"37","author":"Fraser","year":"1987","journal-title":"The Journal of the Royal College of General Practitioners"},{"key":"10.1016\/j.berh.2006.05.006_bib49","first-page":"275","article-title":"A comparison of phenylbutazone and flufenamic acid in the treatment of acute gout","volume":"10","author":"Douglas","year":"1970","journal-title":"Annals of Physical Medicine"},{"key":"10.1016\/j.berh.2006.05.006_bib50","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1016\/S0140-6736(57)91541-6","article-title":"Protracted uricosuric therapy in tophaceous gout","volume":"21","author":"Gutman","year":"1957","journal-title":"Lancet"},{"key":"10.1016\/j.berh.2006.05.006_bib51","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1002\/art.20405","article-title":"A retrospective study of the relationship between serum level and recurrent attacks of gouty arthritis: evidence for reduction of recurrent gouty arthritis with antihyperuricemic therapy","volume":"51","author":"Shoji","year":"2004","journal-title":"Arthritis and Rheumatism"},{"key":"10.1016\/j.berh.2006.05.006_bib52","doi-asserted-by":"crossref","first-page":"179","DOI":"10.7326\/0003-4819-55-2-179","article-title":"Efficacy of colchicine prophylaxis in gout, prevention of recurrent gouty arthritis over a mean period of five years in 208 gouty subjects","volume":"55","author":"Yu","year":"1961","journal-title":"Annals of Internal Medicine"},{"key":"10.1016\/j.berh.2006.05.006_bib53","first-page":"577","article-title":"Treatment of chronic gout. Can we determinne when urates stores are depleted enough to prevent attacks of gout?","volume":"28","author":"Li-Yu","year":"2001","journal-title":"The Journal of Rheumatology"},{"key":"10.1016\/j.berh.2006.05.006_bib54","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1002\/art.10511","article-title":"Effect of urate-lowering therapy on the velocity of size reduction of tophi in chronic gout","volume":"47","author":"Perez-Ruiz","year":"2002","journal-title":"Arthritis and Rheumatism"},{"issue":"supplement","key":"10.1016\/j.berh.2006.05.006_bib55","first-page":"S108","article-title":"Reduction in tophus size in subjects with chronic gout treated with febuxostat or allopurinol for 52 weeks \u2013 FACT trial","volume":"52","author":"Wortmann","year":"2005","journal-title":"Arthritis and Rheumatism"},{"key":"10.1016\/j.berh.2006.05.006_bib56","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1093\/ndt\/gfh629","article-title":"Urate oxidase (rasburicase) for treatment of severe tophaceous gout","volume":"20","author":"Vogt","year":"2005","journal-title":"Nephrology, Dialysis, Transplantation: Official Publication of the European Dialysis and Transplant Association - European Renal Association"},{"issue":"supplement","key":"10.1016\/j.berh.2006.05.006_bib57","first-page":"S105","article-title":"Resolution of tophi with intravenous Peg-uricase in refractory gout","volume":"52","author":"Baraf","year":"2005","journal-title":"Arthritis and Rheumatism"},{"key":"10.1016\/j.berh.2006.05.006_bib58","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1002\/art.1780291209","article-title":"Monosodium urate crystals in the knee joints of patients with asymptomatic, nontophaceous gout","volume":"29","author":"Bomalaski","year":"1986","journal-title":"Arthritis and Rheumatism"},{"key":"10.1016\/j.berh.2006.05.006_bib59","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1097\/00124743-199904000-00003","article-title":"Treatment of chronic gout in patients with renal function impairment. An open, randomized, actively controlled study","volume":"5","author":"Perez-Ruiz","year":"1999","journal-title":"Journal of Clinical Rheumatology"},{"issue":"supplement","key":"10.1016\/j.berh.2006.05.006_bib60","first-page":"S410","article-title":"Ability to attain target serum uric acid level in gout patients on allopurinol","volume":"52","author":"Yang","year":"2005","journal-title":"Arthritis and Rheumatism"},{"key":"10.1016\/j.berh.2006.05.006_bib61","first-page":"1575","article-title":"Compliance with allopurinol therapy among managed care enrollees with gout: a retrospective analysis of administrative claims","volume":"31","author":"Reidel","year":"2004","journal-title":"The Journal of Rheumatology"},{"key":"10.1016\/j.berh.2006.05.006_bib62","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/0002-9343(84)90743-5","article-title":"Severe allopurinol toxicity. Description and guidelines for prevention in patients with renal insufficiency","volume":"76","author":"Hande","year":"1984","journal-title":"The American Journal of Medicine"},{"key":"10.1016\/j.berh.2006.05.006_bib63","first-page":"908","article-title":"A cost effectiveness analysis of urate lowering drugs in nontophaceous recurrent gouty arthritis","volume":"22","author":"Ferraz","year":"1995","journal-title":"The Journal of Rheumatology"},{"key":"10.1016\/j.berh.2006.05.006_bib64","first-page":"S106","article-title":"Impact of serum uric acid on risk of acute gout attacks","volume":"52","author":"Sarawate","year":"2005","journal-title":"Arthritis and Rheumatism"},{"key":"10.1016\/j.berh.2006.05.006_bib65","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1136\/ard.33.4.304","article-title":"Withdrawal of allopurinol in patients with gout","volume":"33","author":"Loebl","year":"1974","journal-title":"Annals of the Rheumatic Diseases"},{"key":"10.1016\/j.berh.2006.05.006_bib66","first-page":"1383","article-title":"Withdrawal of longterm antihyperuricemic therapy in tophaceous gout","volume":"20","author":"Van Lieshout-Zuidema","year":"1993","journal-title":"The Journal of Rheumatology"},{"key":"10.1016\/j.berh.2006.05.006_bib67","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1007\/BF02201004","article-title":"Withdrawal on longterm antihyperuricemic therapy in tophaceous gout","volume":"6","author":"Gast","year":"1987","journal-title":"Clinical Rheumatology"},{"key":"10.1016\/j.berh.2006.05.006_bib68","first-page":"2429","article-title":"Colchicine for prophylaxis of acute flares when initiating allopurinol for chronic gouty arthritis","volume":"31","author":"Borstad","year":"2004","journal-title":"The Journal of Rheumatology"},{"key":"10.1016\/j.berh.2006.05.006_bib69","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1007\/s11926-996-0043-1","article-title":"Diet, alcohol and gout: how do we advise patients given recent developments","volume":"7","author":"Choi","year":"2005","journal-title":"Current Rheumatology Reports"},{"key":"10.1016\/j.berh.2006.05.006_bib70","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1002\/art.20821","article-title":"Beer, liquor, and wine consumption and serum uric acid level: the third national health and nutrition examination survey","volume":"51","author":"Choi","year":"2004","journal-title":"Arthritis and Rheumatism"},{"key":"10.1016\/j.berh.2006.05.006_bib71","first-page":"773","article-title":"Gout: excess calories, purines, and alcohol intake and beyond. Response to a urate-lowering diet","volume":"32","author":"Fam","year":"2005","journal-title":"The Journal of Rheumatology"},{"key":"10.1016\/j.berh.2006.05.006_bib72","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1136\/ard.59.7.539","article-title":"Beneficial effects of weight loss associated with moderate calorie\/carbohydrate restriction, and proportional intake of protein and unsaturated fat on serum urate and lipoprotein levels in gout: a pilot study","volume":"59","author":"Dessein","year":"2000","journal-title":"Annals of the Rheumatic Diseases"},{"key":"10.1016\/j.berh.2006.05.006_bib73","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1002\/art.1780311211","article-title":"Suppression of monosodium urate crystal-induced acute inflammation by diets enriched with gamma-linolenic acid and eicosapentaenoic acid","volume":"31","author":"Tate","year":"1988","journal-title":"Arthritis and Rheumatism"},{"key":"10.1016\/j.berh.2006.05.006_bib74","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1002\/art.21105","article-title":"The effects of vitamin C supplementation on serum concentrations of uric acid: results of a randomized controlled trial","volume":"52","author":"Huang","year":"2005","journal-title":"Arthritis and Rheumatism"},{"key":"10.1016\/j.berh.2006.05.006_bib75","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1093\/jn\/133.6.1826","article-title":"Consumption of cherries lowers serum urate in healthy women","volume":"133","author":"Jacob","year":"2003","journal-title":"The Journal of Nutrition"},{"key":"10.1016\/j.berh.2006.05.006_bib76","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.jep.2004.04.012","article-title":"Xanthine oxidase inhibitors from the leaves of Lagerstroemia speciosa (L.) Pers","volume":"93","author":"Unno","year":"2004","journal-title":"Journal of Ethnopharmacology"},{"key":"10.1016\/j.berh.2006.05.006_bib77","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S0378-8741(98)00119-6","article-title":"Xanthine oxidase inhibitory activity of northeastern North American plant remedies used for gout","volume":"64","author":"Owen","year":"1999","journal-title":"Journal of Ethnopharmacology"},{"key":"10.1016\/j.berh.2006.05.006_bib78","first-page":"77","article-title":"How does patient education affect gout?","volume":"2","author":"Murphy-Bielicki","year":"1984","journal-title":"Clinical Rheumatology Practice"},{"key":"10.1016\/j.berh.2006.05.006_bib79","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1093\/rheumatology\/24.2.155","article-title":"Diuretic-induced gout in elderly women","volume":"24","author":"Macfarlane","year":"1985","journal-title":"British Journal of Rheumatology"},{"key":"10.1016\/j.berh.2006.05.006_bib80","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1097\/00124743-200212000-00003","article-title":"Effect of minidose aspirin on renal function and renal uric acid handing in healthy young adults","volume":"8","author":"Louthrenoo","year":"2002","journal-title":"Journal of Clinical Rheumatology"},{"key":"10.1016\/j.berh.2006.05.006_bib81","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1097\/00004872-200110000-00021","article-title":"Comparative effects of losartan and irbesartan on serum uric acid in hypertensive patients with hyperuricaema and gout","volume":"19","author":"Wurzner","year":"2001","journal-title":"Journal of Hypertension"},{"key":"10.1016\/j.berh.2006.05.006_bib82","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1161\/01.HYP.26.1.112","article-title":"Effects of losartan on a background of hydrochlorothiazide in patients with hypertension","volume":"26","author":"Soffer","year":"1995","journal-title":"Hypertension"},{"key":"10.1016\/j.berh.2006.05.006_bib83","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1136\/ard.62.6.572","article-title":"Effects of combination treatment using anti-hyperuricaemic agents with fenofibrate and\/or losartan on uric acid metabolism","volume":"62","author":"Takahashi","year":"2003","journal-title":"Annals of the Rheumatic Diseases"},{"key":"10.1016\/j.berh.2006.05.006_bib84","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1093\/rheumatology\/keg103","article-title":"Fenofibrate enhances urate reduction in men treated with allopurinol for hyperuricaemia and gout","volume":"42","author":"Feher","year":"2003","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.berh.2006.05.006_bib85","doi-asserted-by":"crossref","first-page":"2147","DOI":"10.1093\/ndt\/gfg341","article-title":"Amlodipine reduces cyclosporine-induced hyperuricaemia in hypertensive renal transplant recipients","volume":"18","author":"Chanard","year":"2003","journal-title":"Nephrology, Dialysis, Transplantation: Official Publication of the European Dialysis and Transplant Association - European Renal Association"},{"key":"10.1016\/j.berh.2006.05.006_bib86","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1136\/ard.33.3.276","article-title":"Effect of oral fructose on urate production","volume":"33","author":"Emmerson","year":"1974","journal-title":"Annals of the Rheumatic Diseases"},{"key":"10.1016\/j.berh.2006.05.006_bib87","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/0026-0495(72)90120-5","article-title":"Studies on the mechanism of fructose-induced hyperuricemia in man","volume":"21","author":"Fox","year":"1972","journal-title":"Metabolism"},{"key":"10.1016\/j.berh.2006.05.006_bib88","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1517\/13543784.14.7.893","article-title":"Febuxostat: a non-purine, selective inhibitor of xanthine oxidase for the management of hyperuricaemia in patients with gout","volume":"14","author":"Schumacher","year":"2005","journal-title":"Expert Opinion on Investigational Drugs"},{"key":"10.1016\/j.berh.2006.05.006_bib89","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1007\/s11926-004-0075-3","article-title":"Serum uric acid lowering therapies: where are we heading in management and the potential role of uricase","volume":"6","author":"Bomalaski","year":"2004","journal-title":"Current Rheumatology Reports"},{"issue":"supplement","key":"10.1016\/j.berh.2006.05.006_bib90","first-page":"501","article-title":"Potent and rapid uricosuric effect of single and repeated doses of EMD 336340 in healthy volunteers","volume":"52","author":"Fourgueray","year":"2005","journal-title":"Arthritis and Rheumatism"},{"key":"10.1016\/j.berh.2006.05.006_bib91","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1002\/art.20781","article-title":"Effects of sevelamer and calcium-based phosphate binders on uric acid concentrations in patients undergoing hemodialysis. A randomized clinical trial","volume":"52","author":"Garg","year":"2005","journal-title":"Arthritis and Rheumatism"},{"key":"10.1016\/j.berh.2006.05.006_bib92","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1097\/00124743-199702000-00009","article-title":"A simple measurement to monitor the size of gouty tophi and rheumatoid nodules","volume":"3","author":"German","year":"1997","journal-title":"Journal of Clinical Rheumatology"},{"key":"10.1016\/j.berh.2006.05.006_bib93","article-title":"Magnetic resonance imaging of gouty tophi during treatment with febuxostat, a non purine selective inhibitor of xanthine oxidase","volume":"50","author":"Schumacher","year":"2004","journal-title":"Arthritis and Rheumatism"},{"key":"10.1016\/j.berh.2006.05.006_bib94","first-page":"v109","article-title":"A survey of indications, results and complications of surgery for tophaceous gout","volume":"115","author":"Kumar","year":"2002","journal-title":"The New Zealand Medical Journal"},{"key":"10.1016\/j.berh.2006.05.006_bib95","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1002\/1529-0131(200101)44:1<231::AID-ANR30>3.0.CO;2-7","article-title":"Efficacy and safety of desensitization to allopurinol following cutaneous reaction","volume":"44","author":"Fam","year":"2001","journal-title":"Arthritis and Rheumatism"},{"key":"10.1016\/j.berh.2006.05.006_bib96","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1097\/00124743-200010000-00005","article-title":"Desensitization to allopurinol after allopurinol hypersensitivity syndrome with renal involvement in gout","volume":"6","author":"Vazquez-Mellado","year":"2000","journal-title":"Journal of Clinical Rheumatology"},{"key":"10.1016\/j.berh.2006.05.006_bib97","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1097\/00124743-200212000-00015","article-title":"My gout and allopurinol desensitization","volume":"8","author":"Hoffman","year":"2002","journal-title":"Journal of Clinical Rheumatology"},{"key":"10.1016\/j.berh.2006.05.006_bib98","doi-asserted-by":"crossref","first-page":"4134","DOI":"10.1073\/pnas.0409500102","article-title":"HLA-B*5801 allele as a genetic marker for servere cutaneous adverse reactions caused by allopurinol","volume":"102","author":"Hung","year":"2005","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.berh.2006.05.006_bib99","doi-asserted-by":"crossref","first-page":"2399","DOI":"10.2165\/00003495-200464210-00003","article-title":"Management of acute and chronic gouty arthritis","volume":"64","author":"Schlesinger","year":"2004","journal-title":"Drugs"},{"key":"10.1016\/j.berh.2006.05.006_bib100","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1007\/s11926-996-0046-y","article-title":"Gout treatment: what is evidence based and how do we determine and promote optimized clinical care?","volume":"7","author":"Mikuls","year":"2005","journal-title":"Current Rheumatology Reports"},{"key":"10.1016\/j.berh.2006.05.006_bib101","doi-asserted-by":"crossref","first-page":"2400","DOI":"10.1002\/art.20438","article-title":"On the brink of novel therapeutic options for an ancient disease","volume":"50","author":"Bieber","year":"2004","journal-title":"Arthritis and Rheumatism"},{"key":"10.1016\/j.berh.2006.05.006_bib102","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1136\/jcp.s3-12.1.205","article-title":"New knowledge on the pathogenesis of gout","volume":"12","author":"Scott","year":"1978","journal-title":"Journal of Clinical Pathology"}],"container-title":["Best Practice &amp; Research Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521694206000544?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521694206000544?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,4,21]],"date-time":"2019-04-21T03:43:12Z","timestamp":1555818192000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521694206000544"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,8]]},"references-count":102,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2006,8]]}},"alternative-id":["S1521694206000544"],"URL":"https:\/\/doi.org\/10.1016\/j.berh.2006.05.006","relation":{},"ISSN":["1521-6942"],"issn-type":[{"value":"1521-6942","type":"print"}],"subject":[],"published":{"date-parts":[[2006,8]]}}}